Verano Holdings Corp. (VRNO)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $5.14
- As of
Kresmion compiles this page from VRNO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Verano Holdings Corp. (VRNO): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-05.
See the full VRNO dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for VRNO on one page. Preview it with sample data, then open it live with a free account.
Preview the VRNO dossierActive signals for VRNO
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 8.5%, EPS $-0.14 vs $-0.153 estimate
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 6.2% - EPS $-0.25 vs $-0.2664 estimate
- mediumEARNINGS_MISS
Q3-2025: Missed consensus by 175.4% - EPS $-0.6 vs $-0.2179 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 347.3% - EPS $-1.35 vs $-0.3018 estimate
- mediumEARNINGS_BEAT
Beat consensus by 6.2% - EPS $-0.25 vs $-0.2664 estimate
FREE, NO ACCOUNT
Every signal on VRNO, as it fires
You are seeing 5 of 11 signals recorded on VRNO since 2026-05-17.
The five above landed across 3 days. The other 6 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, VRNO
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
VRNO against its peers
VRNO's operating margin of -13.0% ranks in the 36th percentile of 17 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-05-31.
| Metric | VRNO | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 822M USD | 165M USD | 91 | 16 |
| Gross margin | 50.3% | 45.1% | 65 | 12 |
| Operating margin | -13.0% | -6.9% | 36 | 17 |
| Net margin | -31.4% | -18.7% | 31 | 17 |
| Return on equity | -36.6% | -16.4% | 28 | 15 |
| 1 year | -30.1% | -30.8% | 53 | 15 |
Peers (19): TKNO, NIKA, KMDA, VREOF, CGC, TLRY, EOLS, ELTP, AQST, CRLBF, ADCT, AKBA, TSNDF, DERM, CRDL, HROW, CRON, BGM, CPIX. Left out: BORAY (no annual filing), EVO (period gap), LFCR (no annual filing), PHBI (period gap), ASRT (no annual filing), OGI (period gap). Fiscal periods ending between 2025-09-30 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (VRNO: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow VRNO on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to VRNO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.